The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer

被引:15
|
作者
Ostheimer, Christian [1 ]
Schweyer, Franziska [1 ]
Reese, Thomas [1 ]
Bache, Matthias [1 ]
Vordermark, Dirk [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany
关键词
NSCLC; osteopontin; radiotherapy; tumor volume; prognostic factors; RADIATION-THERAPY; PROGNOSTIC-FACTOR; NECK-CANCER; HYPOXIA MARKERS; SURVIVAL; HEAD; CHEMORADIOTHERAPY; OXYGENATION; EXPRESSION; VELOCITY;
D O I
10.3892/ol.2016.5104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic quality of increased osteopontin (OPN) plasma levels has been demonstrated for the chemotherapy and surgery of lung cancer. There is also evidence in the literature that tumor volume impacts prognosis in definitive radiotherapy (RT) of (lung) cancer. We previously demonstrated that elevated plasma levels of OPN before, and increasing OPN plasma levels after RT significantly correlate with survival and outcome after curative-intent RT of non-small-cell lung cancer (NSCLC). Tumor volume was also associated with prognosis. The present prospective clinical study investigated the prognostic interrelation of OPN plasma levels and tumor volume and their changes in the radical RT of NSCLC. We evaluated a subset of patients (n=27) with inoperable, non-metastasized NSCLC of the previously published patient collective. Patients were treated with radical radiochemotherapy (2 Gy ad 66 Gy). OPN plasma concentrations were determined by ELISA before (t0), at the end (t1), and 4 weeks after RT (t2). GTV was delineated PET- and CT-correlated before RT (GTV1) and after 40 Gy (GTV2). The course of OPN during and after RT and the change of GTV during RT was monitored over time and correlated with prognosis. Median GTV2 after 40 Gy (63 ml) was significantly lower than pre-RT GTV1 (90 ml, P<0.0001). Median OPN before (t0), at the end of (t1) and four weeks after RT (t2) was 846, 777 and 624 ng/ml and not significantly different. GTV significantly declined by 39 ml during RT (P<0.0001) and OPN non-significantly decreased by 56 ng/ml during (t0 to t1) and by 54 ng/ml after RT (t1 to t2). No correlations were determined between absolute OPN and GTV values or their relative changes during RT. In univariate analysis, only GTV2 significantly predicted overall survival (OS, P=0.03). In multivariate analysis, both OPN t1 (P<0.001) and GTV2 (P=0.001) remained significant predictors of OS. Relative OPN plasma level changes after (t1 to t2) and GTV changes during RT (GTV 1 to GTV 2) significantly predicted OS (P=0.02). The combination of absolute GTV values before RT (GTV1) and GTV changes during RT (GTV1 to 2) were significantly associated with OS in both uni- and multivariate analysis (P=0.03). The combination of absolute OPN plasma levels and their changes with GTV and its changes did not reach statistical significance. The lack of a significant correlation between OPN and GTV together with the finding that OPN and GTV remained independent predictors of survival outcome but were not associated with OS in combination supports the hypothesis that tumor volume (GTV) and OPN plasma levels (both their changes and absolute values) are not interrelated in terms of prognosis but do possess each parameter separately, a prognostic quality in the radical RT of NSCLC which justifies further prospective studies to validate these results.
引用
收藏
页码:3449 / 3456
页数:8
相关论文
共 50 条
  • [21] INVESTIGATION OF THE RELATIONSHIP BETWEEN GROSS TUMOR VOLUME LOCATION AND PNEUMONITIS RATES USING A LARGE CLINICAL DATABASE OF NON-SMALL-CELL LUNG CANCER PATIENTS
    Vinogradskiy, Yevgeniy
    Tucker, Susan L.
    Liao, Zhongxing
    Martel, Mary K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05): : 1650 - 1658
  • [22] Tumor volume shrinkage during stereotactic body radiotherapy is related to better prognoses in patients with stage I non-small-cell lung cancer
    Nam Vu
    Onishi, Hiroshi
    Saito, Masahide
    Kuriyama, Kengo
    Komiyama, Takafumi
    Marino, Kan
    Araya, Masayuki
    Aoki, Shinichi
    Saito, Ryo
    Nonaka, Hotaka
    Funayama, Satoshi
    Watanabe, Hiroaki
    Sano, Naoki
    JOURNAL OF RADIATION RESEARCH, 2020, 61 (05) : 740 - 746
  • [23] A mathematical model for predicting the changes of non-small cell lung cancer based on tumor mass during radiotherapy
    Chen, Jie
    Wang, Keqiang
    Jian, Jianbo
    Zhang, Wenxue
    PHYSICS IN MEDICINE AND BIOLOGY, 2019, 64 (23)
  • [24] Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non-Small Cell Lung Cancer
    Ball, David
    Mitchell, Alan
    Giroux, Dori
    Rami-Porta, Ramon
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 315 - 321
  • [25] Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy
    Dosani, M.
    Yang, R.
    McLay, M.
    Wilson, D.
    Liu, M.
    Yong-Hing, C. J.
    Hamm, J.
    Lund, C. R.
    Olson, R.
    Schellenberg, D.
    CURRENT ONCOLOGY, 2019, 26 (01) : E57 - E63
  • [26] Reasonable Timing of Radiotherapy for Stage IV Non-Small-Cell Lung Cancer During Targeted Therapy Based on Tumour Volume Change
    Li, Qingsong
    Liang, Na
    Zhang, Xia
    Zhang, Yi
    Ouyang, Weiwei
    Su, Shengfa
    Ma, Zhu
    Hu, Yinxiang
    Geng, Yichao
    Chen, Xiaxia
    Lu, Bing
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Radiotherapy and targeted therapies in non-small-cell lung cancer
    Girard, N.
    Mornex, F.
    BULLETIN DU CANCER, 2009, 96 (03) : 311 - 319
  • [28] Palliative percutaneous radiotherapy in non-small-cell lung cancer
    Budach, W
    Belka, C
    LUNG CANCER, 2004, 45 : S239 - S245
  • [29] Chemo-radiotherapy before surgery in stage III non-small-cell lung cancer
    Bonnette, P.
    REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (02) : 105 - 114
  • [30] Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?
    Elsayad, Khaled
    Samhouri, Laith
    Scobioala, Sergiu
    Haverkamp, Uwe
    Eich, Hans Theodor
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (06) : 1165 - 1171